How to Treat COVID-19 Patients at Home in the Italian Context: An Expert Opinion.
Davide Roberto DonnoIgnazio GrattaglianoAlessandro RossiPierangelo Lora AprileGerardo MedeaErik LagolioGuido GranataNicola PetrosilloClaudio CricelliPublished in: Infectious disease reports (2021)
The impact of the coronavirus disease (COVID-19), caused by the novel coronavirus SARS-CoV-2, continues to be widespread, with more than 100 million cases diagnosed in more than 220 countries since the virus was first identified in January 2020. Although patients with mild to moderate forms of COVID-19 could be efficiently managed at home, thus reducing the pressure on the healthcare system and minimizing socio-psychological impact on patients, no trial has been proposed, conducted, or even published on COVID-19 home therapy to date. These expert opinions provide indications on the therapeutical at home management of COVID-19 patients, based on the evidence from the literature and on current guidelines.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- end stage renal disease
- clinical practice
- ejection fraction
- chronic kidney disease
- newly diagnosed
- healthcare
- systematic review
- clinical trial
- study protocol
- physical activity
- depressive symptoms
- cell therapy
- mesenchymal stem cells
- phase ii
- replacement therapy